The Efficacy of Intrathecal Morphine Versus Intrathecal Morphine-Dexamethasone Combination in Cesarean Delivery
Launched by YUZUNCU YIL UNIVERSITY · May 14, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effectiveness of a combination of two medications, morphine and dexamethasone, compared to morphine along with another medication called bupivacaine for pain relief during elective cesarean sections. The goal is to find out which combination works better for managing pain after surgery.
To participate in this trial, you need to be a woman aged between 18 and 40, scheduled for a cesarean section, and planning to have spinal anesthesia. The trial is looking for patients who are in good health but may have had a previous cesarean delivery or are having their second. If you have certain health conditions like high blood pressure, diabetes, or heart and lung diseases, or if you prefer general anesthesia instead of spinal anesthesia, you might not be eligible. If you decide to participate, you can expect to receive one of the medication combinations during your surgery and be monitored for how well it helps with pain relief afterward. Please note that this trial is not yet recruiting participants, but it will be important for women who meet the criteria and are interested in pain management options during cesarean deliveries.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Patients scheduled for caesarean sections
- • Between 18-40 years
- • ASA II group
- • Those who will undergo spinal anesthesia
- • Those between 35-40 weeks of pregnancy
- • 1st and 2nd caesarean sections
- Exclusion Criteria:
- • Those who prefer general anesthesia
- • Those who are outside the age range of 18-40
- • Those who are ASA III and above
- • Those with HT, DM, cardiac and respiratory diseases
- • Preeclampsia, eclampsia, HELLP
- • Those with a history of drug use that affects the cardiovascular system
- • Placenta Previa, Placenta Acreta, Placenta Acreta Those with a history of antiemetic or antidepressant drug use
About Yuzuncu Yıl University
Yüzüncü Yıl University is a distinguished institution committed to advancing healthcare through rigorous clinical research. With a strong emphasis on innovation and collaboration, the university actively engages in various clinical trials aimed at enhancing medical knowledge and improving patient outcomes. Its dedicated research teams are equipped with state-of-the-art facilities and a diverse array of expertise, fostering an environment that promotes ethical standards and scientific excellence. Yüzüncü Yıl University is dedicated to contributing to the global medical community by translating research findings into practical applications for improved health and well-being.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Nurettin KURT, Assoc.Prof
Principal Investigator
YüzüncüYıl
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported